| EORTC/MSGERC | European Organization for Research and Treatment of Cancer/Mycoses Study Group Education and Research Consortium |
| IPFI | Invasive pulmonary fungal infection |
| ICU | Intensive care unit |
| IPA | Invasive pulmonary aspergillosis |
| SARI | Severe acute respiratory infections |
| IAPA | Invasive-associated pulmonary aspergillosis |
| CAPA | COVID-19-associated pulmonary aspergillosis |
| GM | Galactomannan |
| BAL | bronchoalveolar lavage |
| IS | Induced sputum |
| URT | Upper respiratory tract |
| CSF | cerebrospinal fluid |
| PEB | paraffin-embedded samples |
| CNS | central nervous system |
| EIA | Enzyme immunoassay |
| CLIA | chemiluminescent immunoassays |
| ODI | optical density index |
| LFA/LFD | lateral flow assay/device |
| TAT | turnaround time |
| POC | point-of-care |
| PCR | Polymerase chain reaction |
| AMP | anti-mold prophylaxis |
| DM | diabetes mellitus |
| ROCM | rhino-orbito-cerebral mucormycosis |
| IPM | invasive pulmonary mucormycosis |
| PJP | Pneumocystis jirovecii pneumonia |
| BDG | β-D-glucan detection |
| qPCR | Quantitative PCR |